ABL1 and autosomal dominant polycystic kidney disease: These findings corroborate existing literature - which is drawn upon by the multiscale interactome method to make inferences - by replicating direct inhibition of VEGF2 and Abl by mebendazole (Dakshanamurthy et al., 2012; Issa et al., 2015; Ariey-Bonnet et al., 2020), and also extend these studies by implicating mebendazole in the inhibition of additional ADPKD-relevant kinase targets it has not previously been demonstrated to interact with.